Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antoniou

Showing results (241-250 of 395) with videos related to

Pageof 40
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE studyFabio Girardi, Daniel R Barnes, Daniel Barrowdale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancerElena Castro, Chee Goh, David Olmos, et al.
Journal of Medical Genetics|December 28, 2023
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory surveySophie Allen, Lucy Loong, Alice Garrett, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Clinical Breast Cancer|February 5, 2026
Canadian Women's Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I ProjectJennifer D Brooks, Kristina M Blackmore, Nguyet N M Ngo, et al.
The British Journal of Dermatology|March 29, 2019
Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patientsF Benhadou, H H Van der Zee, J C Pascual, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Human Mutation|August 22, 2021
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variantsGorka Ruiz de Garibay, Ignacio Fernandez-Garcia, Sylvie Mazoyer, et al.
Journal of Medical Genetics|February 2, 2018
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes <i>SDHB</i>, <i>SDHC</i> and <i>SDHD</i>Katrina A Andrews, David B Ascher, Douglas Eduardo Valente Pires, et al.
Pageof 40

Showing results (241-250 of 395) with videos related to

Sort By:
Pageof 40
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE studyFabio Girardi, Daniel R Barnes, Daniel Barrowdale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancerElena Castro, Chee Goh, David Olmos, et al.
Journal of Medical Genetics|December 28, 2023
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory surveySophie Allen, Lucy Loong, Alice Garrett, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Clinical Breast Cancer|February 5, 2026
Canadian Women's Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I ProjectJennifer D Brooks, Kristina M Blackmore, Nguyet N M Ngo, et al.
The British Journal of Dermatology|March 29, 2019
Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patientsF Benhadou, H H Van der Zee, J C Pascual, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Human Mutation|August 22, 2021
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variantsGorka Ruiz de Garibay, Ignacio Fernandez-Garcia, Sylvie Mazoyer, et al.
Journal of Medical Genetics|February 2, 2018
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes <i>SDHB</i>, <i>SDHC</i> and <i>SDHD</i>Katrina A Andrews, David B Ascher, Douglas Eduardo Valente Pires, et al.
Pageof 40